State guide

Delaware's state employee plan and GLP-1s

If you're on Delaware's state employee health plan, GLP-1s for weight loss are still covered — and from July 1, 2026 they cost $200 a month at the counter. The minutes show the committee rejected a $132 copay first, by six votes to five.

Every source on this page was read in September 2026. Each one is dated below with the date printed on the document itself.

All state guides

What changed, and what the document says

Point	Status	What the source says
What passed	Conditions apply	A flat $200 per 30-day supply, for the non-Medicare population, from July 1, 2026. “Secretary Gordon made a motion, which was seconded by Lt. Gov. Gay, to adopt Option 2, implementing a stand-alone copay of $200 per 30-day supply for weight loss GLP-1 medications, effective July 1, 2026, for the non-Medicare population.” State of Delaware, State Employee Benefits Committee — March 9, 2026
What failed first	Context	A $132 copay, contingent on manufacturer assistance staying available. It lost on a named roll call before the $200 motion carried. “implement a stand-alone copay of $132 per month contingent upon the continued availability of the copay assistance program.” State of Delaware, State Employee Benefits Committee — March 9, 2026
What was on the table	Context	Ending coverage entirely was one of the options the committee considered. “Mr. Stitzel reviewed several policy options for the Committee's consideration effective July 1, 2026, including eliminating coverage, implementing stand-alone or integrated copay structures of $120, $132 and $200, removing prior authorization requirements in exchange for enhanced rebate pricing, or maintaining the current copay structure.” State of Delaware, State Employee Benefits Committee — March 9, 2026
What drove it	Context	Projected plan spending of about $92.1 million for the fiscal year, on a benefit that started in July 2023. “Mr. Stitzel reported that utilization and costs associated with GLP-1 medications for weight loss have increased significantly since the benefit was initially implemented in July 2023. Updated projections estimate gross plan spending of approximately $92.1 million for Fiscal Year 2026.” State of Delaware, State Employee Benefits Committee — March 9, 2026

Which of these companies serve Delaware?

Of the 28 companies we grade, 4 publish a list of the states they are licensed in. We checked 23 more and found no such list on any page we read; 1 we have not checked either way.

3 of those lists name Delaware: Gala Health, Care Bare Rx and Vita Bella. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

If you're paying cash instead

None of the above changes what a telehealth seller charges you. These are the graded reviews worth reading first from here:

Alan Meds — Publishes a month-to-month semaglutide price you can hold against a $200 copay without doing arithmetic first.
Zealthy — Its advertised figure and its month-two figure are far apart, which matters more when you have a fixed copay to compare with.
Ro — Brand-name pricing, published per drug and per dose, at $349 and $449 once the starter doses end.

Our grading method and how we verify a price explain what those letters mean.

Sources

Each document below was fetched and read in September 2026. The date shown is the one printed on the document, which is not always the date in its web address.

Minutes from the Meeting of the State Employee Benefits Committee — State of Delaware, State Employee Benefits Committee. the meeting date on the masthead and in the running footer: March 9, 2026. Read September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.